Home > Insider Trading > Filing (0001209191-23-024058)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1788028	Jasper Therapeutics Inc.	JSPR	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1242126	Mark Mcdade	C/O Qiming U.s. Ventures Management, Llc 11100 Ne 8Th St., Suite 200 Bellevue WA 98004	No	No	Yes	No
1248153	E Gary Rieschel	C/O Qiming U.s. Ventures Management, Llc 11100 Ne 8Th St., Suite 200 Bellevue WA 98004	No	No	Yes	No
1765710	Qiming U.s. Healthcare Fund Ii, L.p.	11100 Ne 8Th St., Suite 200 Bellevue WA 98004	No	No	Yes	No
1868862	Qiming U.s. Healthcare Gp Ii, Llc	11100 Ne 8Th St., Suite 200 Bellevue WA 98004	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Voting Common Stock	Acquisiton	2023-01-27	2,666,666	$1.50	8,519,648	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. Each of Qiming GP and Messrs. Rieschel and McDade disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.